Abstract
Objective
Data on the global prevalence of chronic rhinosinusitis (CRS) is significantly varied and limited across countries and over time. Therefore, we aimed to conduct a comprehensive investigation into the global, regional, and national burden of CRS from the years 1980 to 2021, as well as identify those factors that influence levels of such burden.Design
We conducted a systematic review and meta-analysis of general population-based observational studies focusing on CRS. We calculated pooled estimates of CRS prevalence and incidence with 95% confidence intervals (CIs). Subgroup analyses were conducted stratifying by sex, age cohorts, geographic regions, smoking status, obesity, and comorbid conditions.Data sources
PubMed/MEDLINE, EMBASE, CINAHL, Google Scholar, and Cochrane databases.Eligibility criteria for selection
We included general population-based observational studies on CRS published from database inception through October 20, 2023.Results
A total of 28 eligible studies, encompassing more than 237 million participants and 11,342,923 patients with CRS from 20 countries across four continents, were included in the analysis. Global pooled prevalence of CRS and CRS with nasal polyps (CRSwNP) was found to be 8.71% (95% CI, 6.69-11.33; number of studies, 20) and 0.65% (95% CI, 0.56-0.75; number of studies, 4), respectively. The prevalence of CRS was greater in Europe compared with North America, South America, and Asia; adults compared with children; smokers compared with never-smoker; those with obesity compared with normal weight; and those with comorbidities such as asthma, diabetes mellitus, eczema, and nasal septal deviation. Pooled prevalence of CRS increased from 1980 to 2020 (1980-2000: 4.72%; 95% CI, 2.12-10.49; 2014-2020: 19.40%; 95% CI, 12.12-31.07). Similar patterns were observed in CRS incidence.Conclusions
Our study provides valuable insights into CRS prevalence and incidence across diverse demographic and clinical factors, highlighting its increasing global burden. The reported prevalence of CRS varies internationally, and may be increasing over time. To enhance data quality and comparability, standardization of reporting methodologies is imperative.Systematic review registration
PROSPERO (registration no. CRD42024527805).Citations & impact
This article has not been cited yet.
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/170167579
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Cochrane Database Syst Rev, 2(2022), 01 Feb 2022
Cited by: 12 articles | PMID: 36321557 | PMCID: PMC8805585
Review Free full text in Europe PMC
Global Incidence and Prevalence of Eosinophilic Esophagitis, 1976-2022: A Systematic Review and Meta-analysis.
Clin Gastroenterol Hepatol, 21(13):3270-3284.e77, 17 Jun 2023
Cited by: 24 articles | PMID: 37331411
Review
Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis.
EClinicalMedicine, 65:102280, 17 Oct 2023
Cited by: 12 articles | PMID: 37876996 | PMCID: PMC10590724
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force
Agency for Healthcare Research and Quality (US), Rockville (MD), 26 Oct 2018
Cited by: 0 articles | PMID: 30354042
ReviewBooks & documents Free full text in Europe PMC
Funding
Funders who supported this work.
the ITRC (Information Technology Research Center) support program (1)
Grant ID: IITP-2024-RS-2024-00438239
the National Research Foundation of Korea (1)
Grant ID: RS-2023-00248157